Cytarabine-induced pericarditis: a case report and review of the literature of the cardio-pulmonary complications of cytarabine therapy.
Pericarditis is a rare complication of chemotherapy. This report describes a patient who developed symptoms, signs, and electrocardiographic evidence of pericarditis following treatment with high dose cytarabine. The patient had no clinical or echocardiographic evidence of infection or leukemic involvement of the pericardium. Isolated pericarditis associated with high dose cytarabine has been rarely reported. This therapy is frequently used and, therefore, it seems prudent to alert physicians to this potential complication of cytarabine. The cardiopulmonary complications of cytarabine are also reviewed.
Reykdal
S
S
Department of Medicine, Rochester General Hospital, NY 14621.
Sham
R
R
Kouides
P
P
D003561:Cytarabine / Q000009:adverse effects*; D004562:Electrocardiography; D006801:Humans; D008297:Male; D008875:Middle Aged; D010493:Pericarditis / Q000139:chemically induced*; D012128:Respiratory Distress Syndrome / Q000139:chemically induced*
D003561:Cytarabine